Safety and Efficacy of Pembrolizumab Monotherapy in Patients With Previously Treated Advanced Gastric and Gastroesophageal Junction Cancer

S. Fuchs, Charles; Doi, Toshihiko; Woo-Jun Jang, Raymond; Muro, Kei; Satoh, Taroh; Machado, Manuela; Sun, Weijing; I. Jalal, Shadia; A. Shah, Manish; Metges, Jean-Phillipe; Garrido, Marcelo; Golan, Talia; Mandalà, Mario; A. Wainberg, Zev; V.T. Catenacci, Daniel; Ohtsu, Atsushi; Shitara, Kohei; Geva, Ravit; Bleeker, Jonathan; H. Ko, Andrew; Y. Ku, Geoffrey; Philip, Philip; C. Enzinger, Peter; Bang, Yung‐Jue; Levitan, Diane; Wang, Jiangdian; Koshiji Rosales, Minori; P. Dalal, Rita; H. Yoon, Harry

doi:10.1001/jamaoncol.2018.0013

Public

Safety and Efficacy of Pembrolizumab Monotherapy in Patients With Previously Treated Advanced Gastric and Gastroesophageal Junction Cancer

Published in JAMA Oncology • Mar 15, 2018

Authors:

Charles S. Fuchs

Toshihiko Doi

Raymond Woo-Jun Jang

Abstract

Importance: Therapeutic options are needed for patients with advanced gastric cancer whose disease has progressed after 2 or more lines of therapy. Objective: To evaluate the safety and efficacy of pembrolizumab in a cohort of patients with previously treated gastric or gastroesophageal junction can...

Subject

Medicine

Pembrolizumab

Internal medicine

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!